Many Africans stop HIV treatment because of cost and travelBMJ 2007; 335 doi: https://doi.org/10.1136/bmj.39374.533333.DB (Published 25 October 2007) Cite this as: BMJ 2007;335:848
- Michael Day
Half of patients in sub-Saharan Africa who take antiretroviral drugs die or discontinue treatment within two years of starting it, new research shows.
For many patients treatment centres are too far away or the cost of drugs too high. Other patients start antiretroviral treatment too late or are deterred by the side effects, say US and South African researchers in a review in PLoS Medicine (2007;4:e298).
Their review of the literature indicates that around 40% of patients were lost to treatment after two years. They estimate, however, that the true figure is likely to be around 50%.
The review's lead author, Sydney Rosen, of the …